Skip to main content

Table 1 Overview of venue and participant selection procedures for each for the venue types

From: Programmatic options for monitoring malaria in elimination settings: easy access group surveys to investigate Plasmodium falciparum epidemiology in two regions with differing endemicity in Haiti

 

Primary school

Health facility

Churches

Region venue sampled

Artibonite; Grand’Anse

Artibonite; Grand’Anse

Artibonite

Venue

 Sampling frame

Government and non-governmental

Government and non-governmental

Convenience census

 Inclusion criteria

At least 100 pupils registered

Staffed daily with clinician attending patients

At least 100 regular attendees

 Sampling strategy

- Stratified random sample according to remoteness measured as distance to main roads

- N = 21 (Artibonite); N = 25 (Grand’Anse)

- Census of all functioning facilities

- N = 9 (Artibonite); N = 16 (Grand’Anse)

- Stratified random sample by sub-commune and denomination

- N = 9 (Artibonite)

Participant

 Target sample size

- 150 pupils per school

- A total of 450 individuals per facility

- 150 individuals per each age category (6 months to 5 years; 6–15 years; > 15 years)

- All attendees

 Sampling strategy

- Pupils in class 2 to 6

- 25 pupils per class selected by random number table

- All patients attending the health facility above 6 months of age not requiring urgent medical attention

- All people accompanying patients above 6 months of age

- Above 6 months of age

- Attended the church service

 Consent

- Written from school director

- Community parental meetings, with opt-out consent

- Assent from children

- Written informed consent

- Written assent for children 7 to 17 years old

- Written informed consent

- Written assent for children 7 to 17 years old

 Geolocation strategy

- All hsRDT-positive individuals by handheld GPS

- Random selection of 30% of people testing hsRDT negative by GPS trackers and/or handheld GPS

- All coordinates collected by handheld GPS

- All hsRDT-positive individuals

- Random selection of 30% of people testing hsRDT negative

- None